ArticleJournal of orthopaedics2025
Low risk of periprosthetic fracture and subsidence with automated impaction device in arthroplasty following femoral neck fracture: A retrospective study.
Article in Journal of orthopaedics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Manual broaching in hip arthroplasty for femoral neck fractures (FNFx) may introduce variability in force application, increasing the risk of periprosthetic fractures. Automated impaction devices (AID) deliver consistent, uniform force vectors during femoral preparation, potentially reducing implant-bone mismatch, stem subsidence, and fracture risk. This study evaluates early complication rates following AID use in hip arthroplasty for FNFx. Methods: A retrospective cohort study was conducted on consecutive patients undergoing total hip arthroplasty (THA) or hemiarthroplasty (HA) for FNFx by two surgeons between January 1, 2019, and June 1, 2023. All patients received a cementless femoral stem implanted with an AID and had a minimum 30-day follow-up. Outcomes assessed included 30-day revision-free stem survivorship, intraoperative and postoperative periprosthetic fractures, femoral component subsidence, and 30-day reoperation and readmission rates. Results: The cohort included 118 patients [72.0 % women; mean age 77.4 (range, 52-95) years], with 82 (69.5 %) undergoing THA and 36 (30.5 %) HA. One intraoperative fracture (0.8 %, Vancouver AG) and one postoperative fracture (0.8 %, Vancouver B1) occurred. The 30-day reoperation rate was 3.4 % (n = 4), and the readmission rate was 16.3 % (n = 15). Mild femoral component subsidence occurred in 1.7 % (n = 2) without evidence of loosening. No femoral stem revisions were reported within 30 days, yielding a 100 % short-term survivorship rate. Conclusion: Early outcomes suggest that AID use in hip arthroplasty for FNFx is associated with low rates of periprosthetic fracture, subsidence, and early complications. Further prospective studies are needed to assess long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.